Microglia in pediatric brain tumors: The missing link to successful immunotherapy

Research output: Contribution to journalArticlepeer-review

Abstract

Brain tumors are the leading cause of cancer-related mortality in children. Despite the development of immunotherapeutic strategies for adult brain tumors, progress in pediatric neuro-oncology has been hindered by the complex and poorly understood nature of the brain's immune system during early development, a phase that is critical for the onset of many pediatric brain tumors. A defining characteristic of these tumors is the abundance of microglia, the resident immune cells of the central nervous system. In this review, we explore the concept of microglial diversity across brain regions and throughout development and discuss how their maturation stage may contribute to tumor growth in children. We also summarize the current knowledge on the roles of microglia in common pediatric brain tumor entities and provide examples of myeloid-based immunotherapeutic strategies. Our review underscores the importance of microglial plasticity in pediatric brain tumors and its significance for developing effective immunotherapeutic strategies.

Original languageEnglish
Pages (from-to)101246
JournalCell Reports Medicine
Volume4
Issue number11
DOIs
Publication statusPublished - 21 Nov 2023

Keywords

  • Child
  • Humans
  • Microglia/physiology
  • Brain Neoplasms/therapy
  • Central Nervous System
  • Brain
  • Immunotherapy

Fingerprint

Dive into the research topics of 'Microglia in pediatric brain tumors: The missing link to successful immunotherapy'. Together they form a unique fingerprint.

Cite this